Valuation: Divi's Laboratories Limited

Market Cap 2,442B 25.46B 22.05B 20.85B 18.88B 35.43B 35.69B 249B 95.72B 1,238B 95.62B 93.5B 3,949B P/E 2027 *
74.9x
P/E 2028 * 62.1x
Enterprise Value 2,407B 25.09B 21.73B 20.55B 18.61B 34.92B 35.18B 245B 94.35B 1,220B 94.25B 92.16B 3,892B EV / Sales 2027 *
19.1x
EV / Sales 2028 * 16x
Free-Float
48.01%
Yield 2027 *
0.38%
Yield 2028 * 0.42%
1 day-1.33%
1 week-1.26%
Current month-2.84%
1 month+8.51%
3 months+38.57%
6 months+51.51%
Current year+43.89%
1 week 9,118.5
Extreme 9118.5
9,615
1 month 8,457.5
Extreme 8457.5
9,615
Current year 5,647.5
Extreme 5647.5
9,615
1 year 5,636.5
Extreme 5636.5
9,615
3 years 3,295.3
Extreme 3295.3
9,615
5 years 2,730
Extreme 2730
9,615
10 years 532.65
Extreme 532.65
9,615
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.33%-1.26%+52.63%+140.92% 25.82B
-0.34%+1.20%+52.08%+97.66% 1,015B
-0.25%-1.03%+50.13%+64.96% 642B
+0.16%+5.42%+20.52%+72.41% 463B
-0.22%+2.88%+38.48%+37.98% 353B
-0.07%+1.82%+16.57%+23.39% 265B
-0.31%+2.02%+6.15%+10.75% 254B
-1.09%-3.92%+37.70%+44.93% 206B
-1.60%-5.51%-22.30%-58.60% 191B
+0.16%-0.35%+29.85%+93.11% 182B
Average -0.56%-2.78%+28.18%+52.75% 359.6B
Weighted average by Cap. -0.37%-2.18%+34.57%+59.84%

Financials

2027 *2028 *
Net sales 126B 1.31B 1.14B 1.07B 972M 1.82B 1.84B 12.81B 4.93B 63.76B 4.92B 4.82B 203B 150B 1.56B 1.35B 1.28B 1.16B 2.17B 2.19B 15.27B 5.88B 76.01B 5.87B 5.74B 242B
Net income 32.65B 340M 295M 279M 252M 474M 477M 3.33B 1.28B 16.55B 1.28B 1.25B 52.8B 39.42B 411M 356M 337M 305M 572M 576M 4.02B 1.55B 19.99B 1.54B 1.51B 63.74B
Net Debt -35B -365M -316M -299M -271M -508M -512M -3.57B -1.37B -17.75B -1.37B -1.34B -56.6B -44.85B -468M -405M -383M -347M -651M -656M -4.57B -1.76B -22.74B -1.76B -1.72B -72.53B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
15/09/26 INR 9,198.00 -1.33% 380,826
11/09/26 INR 9,322.00 -1.23% 516,756
10/09/26 INR 9,438.50 -0.52% 338,181
09/09/26 INR 9,488.00 -0.91% 385,273
08/09/26 INR 9,575.00 +2.79% 838,906
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,198.00INR
Average target price
8,447.00INR
Spread / Average Target
-8.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!